Vacuum erection devices (VED) are becoming first-line therapies for erectile dysfunction and preservation (rehabilitation) of erectile function following treatment for prostate cancer. Currently, phosphodiesterase-5 inhibitors have limited efficacy in elderly patients or patients with moderate to severe diabetes, hypertension, and coronary artery disease. Alternative therapies, such as VED, have emerged as a primary option for patients refractory to oral therapy. VED has also been successfully used in combination treatment with oral therapy and penile injections. More recently, there has been interest in the use of VED in early intervention protocols to encourage corporeal rehabilitation and prevention of post-radical prostatectomy venoocclusive dysfunction. This is evident by the preservation of penile length and girth seen with the early use of the VED following radical prostatectomy. There are ongoing studies to help preserve penile length and girth with early use of VED following prostate brachytherapy and external beam radiation for prostate cancer. Recently, there has also been interest in VED to help maintain penile length following surgical correction of Peyronie’s disease and to increase penile size before implantation of the penile prosthesis.
This is a preview of subscription content, access via your institution.
Buy single article
Instant access to the full article PDF.
Tax calculation will be finalised during checkout.
Subscribe to journal
Immediate online access to all issues from 2019. Subscription will auto renew annually.
Tax calculation will be finalised during checkout.
References and Recommended Reading
Nandipati KC, Raina R, Agarwal A, Zippe CD: Erectile dysfunction following radical retropubic prostatectomy: epidemiology, pathophysiology and pharmacological management. Drugs Aging 2006, 23:101–117.
Glass C, Soni B: ABC of sexual health: sexual problems of disabled patients. BMJ 1999, 318:518–521.
Donnelly R, Emslie-Smith AM, Gardner ID, Morris AD: ABC of arterial and venous disease: vascular complications of diabetes. Br Med J 2000, 320:1062–1066.
Kaye JA, Jick H: Incidence of erectile dysfunction and characteristics of patients before and after the introduction of sildenafil in the United Kingdom: cross sectional study with comparison patients. BMJ 2003, 326:424–425.
Levine LA, Dimitriou RJ: Vacuum constriction and external erection devices in erectile dysfunction. Urol Clin North Am 2001, 28:335–341.
Raina R, Agarwal A, Allamaneni SS, et al.: Sildenafil citrate and vacuum constriction device combination enhances sexual satisfaction in erectile dysfunction after radical prostatectomy. Urology 2005, 65:360–364.
Bratton RL, Cassidy HD: Vacuum erection device use in elderly men: a possible severe complication. J Am Board Fam Pract 2002, 15:501–502.
Utida C, Truzzi JC, Bruschini H, et al.: Male infertility in spinal cord trauma. Int Braz J Urol 2005, 31:375–383.
Sidi AA, Lewis JH: Clinical trial of a simplified vacuum erection device for impotence treatment. Urology 1992, 39:526–528.
Vrijhof HJ, Delaere KP: Vacuum constriction devices in erectile dysfunction: acceptance and effectiveness in patients with impotence of organic or mixed etiology. Br J Urol 1994, 74:102–105.
Bosshardt RJ, Farwerk R, Sikora R, et al.: Objective measurement of the effectiveness, therapeutic success and dynamic mechanisms of the vacuum device. Br J Urol 1995, 75:786–791.
Baltaci S, Aydos K, Kosar A, Anafarta K: Treating erectile dysfunction with a vacuum tumescence device: a retrospective analysis of acceptance and satisfaction. Br J Urol 1995, 76:757–760.
Lewis RW, Witherington R: External vacuum therapy for erectile dysfunction: use and results. World J Urol 1997, 15:78–82.
Zippe C, Nandipati K, Agarwal A, Raina R: Sexual dysfunction after pelvic surgery. Int J Impot Res 2006, 18:1–18.
Turner LA, Althof SE, Levine SB, et al.: External vacuum devices in the treatment of erectile dysfunction: a one-year study of sexual and psychosocial impact. J Sex Marital Ther 1991, 17:81–93.
Van Thillo EL, Delaere KP: The vacuum erection device. A noninvasive treatment for impotence. Acta Urol Belg 1992, 60:9–13.
Meuleman EJ: Experiences with a vacuum apparatus in the treatment of erection disorders. Ned Tijdschr Geneeskd [in Dutch]. 1993, 137:412–416.
Derouet H, Caspari D, Rohde V, et al.: Treatment of erectile dysfunction with external vacuum devices. Andrologia 1999, 31:89–94.
Mulhall JP: Intracavernosal injection therapy: a practical guide. Tech Urol 1997, 3:129–134.
Purvis K, Egdetveit I, Christiansen E: Intracavernosal therapy for erectile failure—impact of treatment and reasons for drop-out and dissatisfaction. Int J Impot Res 1999, 11:287–299.
Sundaram CP, Thomas W, Pryor LE, et al.: Long-term follow-up of patients receiving injection therapy for erectile dysfunction. Urology 1997, 49:932–935.
Nunez Mora C, Rios Gonzalez E, Martinez-Pineiro Lorenzo L, et al.: Treatment of erectile dysfunction with vacuum devices [in Spanish]. Arch Esp Urol 2000, 53:819–825.
Seckin B, Atmaca I, Ozgok Y, et al.: External vacuum device therapy for spinal cord injured males with erectile dysfunction. Int Urol Nephrol 1996, 28:235–240.
Aloui R, Iwaz J, Kokkidis MJ, Lavoisier P: A new vacuum device as alternative treatment for impotence. Br J Urol 1992, 70:652–655.
Turner LA, Althof SE, Levine SB, et al.: Treating erectile dysfunction with external vacuum devices: impact upon sexual, psychological and marital functioning. J Urol 1990, 144:79–82.
Finelli A, Hirshberg ED, Radomski SB: The treatment of choice for elderly patients with erectile dysfunction. Geriatr Nephrol Urol 1998, 8:15–19.
Hatzimouratidis K, Hatzichristou DG: A comparative review of the options for treatment of erectile dysfunction: which treatment for which patient? Drugs 2005, 65:1621–1650.
Hackett GI: Patient preferences in treatment of erectile dysfunction: the continuing importance of patient education. Clin Cornerstone 2005, 7:57–65.
Lewis RW, Newell MM: The role of vacuum device therapy in the management of erectile dysfunction. US Kid Urol Dis, Touch Briefing 2005:112–115.
Sperling H, Lummen G, Schneider T, Rubben H: New treatment options for erectile dysfunction. Pharmacologic and non-pharmacologic options [in German]. Herz 2003, 28:314–324.
Gauthier A, Rutchik DS, Winters CJ, et al.: Relative efficacy of sildenafil compared to other treatment options for erectile dysfunction. South Med J 2000, 93:962–965.
Chen J, Mabjeesh NJ, Greenstein A: Sildenafil versus vacuum erection device: patient preference. J. Urol 2001, 166:1779–1781.
Moul JW, McLeod DG: Negative pressure devices in the explanted penile prosthesis population. J Urol 1989, 142:729–731.
Chen J, Sofer M, Kaver I, et al.: Concomitant use of sildenafil and a vacuum entrapment device for the treatment of erectile dysfunction. J Urol 2004, 171:292–295.
Shamloul R: Management of honeymoon impotence. J Sex Med 2006, 3:361–366.
Wylie KR, Jones RH, Walters S: The potential benefit of vacuum devices augmenting psychosexual therapy for erectile dysfunction: a randomized controlled trial. J Sex Marital Ther 2003, 29:227–236.
Soderdahl DW, Petroski RA, Mode D, et al.: The use of an external vacuum device to augment a penile prosthesis. Tech Urol 1997, 3:100–102.
Israilov S, Shmuely J, Niv E, et al.: Evaluation of a progressive treatment program for erectile dysfunction in patients with diabetes mellitus. Int J Impot Res 2005, 17:431–436.
Marmar JL, DeBenedictis TJ, Praiss DE: The use of a vacuum constrictor device to augment a partial erection following an intracavernous injection. J Urol 1988, 140:975–979.
Ciancio SJ, Kim ED: Penile fibrotic changes after radical retropubic prostatectomy. BJU Int 2000, 85:101–106.
Munding M, Wessels H, Dalkin B: Pilot study of changes in stretched penile length 3 months after radical retropubic prostatectomy. Urology 2001, 58:567–569.
Savoie M, Kim S, Soloway M: A prospective study measuring penile length in men treated with radical prostatectomy for prostrate cancer. J Urol 2003, 169:1462–1464.
Dalkin B: Preservation of penile length after radical prostatectomy (RP). Early intervention with a vacuum erection device (VED) [abstract]. Presented at the Society of Urologic Oncology Meeting. Anaheim, CA; May 19–14, 2007.
Köhler T, Pedro R, Hendlin K: A pilot study of early use of vacuum erection device after radical retropubic prostatectomy. BJU 2007, 100, 858–862.
McCullough AR: Prevention and management of erectile dysfunction following radical prostatectomy. Urol Clin North Am 2001, 28:613–627.
Pahlajani G, Ali M, Zippe C: Early intervention with PDE-5 inhibitors following prostate brachytherapy improves subsequent erectile function [abstract]. Presented at the Annual Meeting of the American Society for Therapeutic Radiology; Boston, MA; September 21–25, 2008.
Lue T, Ahmed E: Lengthening shortened penis caused by Peyronie’s disease using circular venous grafting and daily stretching with a vacuum erection device. J Urol 1999, 161:1141–1144.
Colombo F, Garner A, Cozenage A: Early rehabilitation with vacuum device following sphenoid graft surgery for Peyronie’s disease. Eur Urol 2000, 180(Suppl 1):180.
Sellers T, Dineen M, Wilson SK: Vacuum protocol and cylinders that lengthen allow implantation of longer, inflatable prosthesis [abstract]. Presented at the Fall Meeting of the Society of Sexual Medicine. Toronto, Canada; October 16–19, 2008.
Tan HL: Economic cost of male erectile dysfunction using a decision analytic model: for a hypothetical managed-care plan of 100,000 members. Pharmacoeconomics 2000, 17:77–107.
Nadig PW, Ware JC, Blumoff R: Noninvasive device to produce and maintain an erection-like state. Urology 1986, 27:126–131.
Gontero P, Kirby R: Proerectile pharmacological prophylaxis following nerve-sparing radical prostatectomy (NSRP). Prostate Cancer Prostatic Dis 2004, 7:223–226.
Moore RA, Derry S, McQuay HJ: Indirect comparison of interventions using published randomized trials: systematic review of PDE-5 inhibitors for erectile dysfunction. BMC Urol 2005, 5:18.
McMahon CG: Erectile dysfunction. Med J Aust 2000, 173:492–497.
Montague DK, Angermeier KW: Contemporary aspects of penile prosthesis implantation. Urol Int 2003, 70:141–146.
Wagner G, Saenz de Tejada I: Update on male erectile dysfunction. BMJ 1998, 316:678–682.
Shabsigh R, Padma-Nathan H, Gittleman M, et al.: Intracavernous alprostadil alfadex (EDEX/VIRIDAL) is effective and safe in patients with erectile dysfunction after failing sildenafil (Viagra). Urology 2000, 55:477–480.
McMahon CG: Comparison of the response to the intracavernosal injection of a combination of papaverine and phentolamine, prostaglandin E1 alone and a combination of all three in the management of impotence. Int J Impot Res 1991, 3:133–142.
Carson CC: Penile prostheses: are they still relevant? BJU Int 2003, 91:176–177.
Zippe C, Pahlajani G: Penile rehabilitation following radical prostatectomy: role of early intervention and chronic therapy. Urol Clin North Am 2007, 34:601–618.
Monga M, Köhler T, Hendlin K: Early use of vacuum constriction device following radical retropubic prostatectomy: a randomized clinical trial. Urology 2006, 68:262.
About this article
Cite this article
Zippe, C.D., Pahlajani, G. Vacuum erection devices to treat erectile dysfunction and early penile rehabilitation following radical prostatectomy. Curr Urol Rep 9, 506–513 (2008). https://doi.org/10.1007/s11934-008-0086-0
- Erectile Dysfunction
- Radical Prostatectomy
- Radical Retropubic Prostatectomy
- Penile Prosthesis